DS
SXTP icon

DRW Securities’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

DRW Securities’s Portfolio SXTP Stock Details SXTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,303
Closed -$37.3K – 1684
2025
Q3 		$37.3K Buy
+6,303
New +$38.4K ﹤0.01% 1237

Other funds holding SXTP

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DRW Securities's SXTP Position: Q4 2025 in Review

DRW Securities sold out of 60 Degrees Pharmaceuticals (SXTP) in Q4 2025, closing a stake of 6,303 shares — an estimated $37.3K sold.

DRW Securities first reported a position in SXTP in Q3 2025 and held it in 1 quarter. The position peaked at $37.3K in Q3 2025. 7 funds tracked by Wall St. Rank hold SXTP as of Q4 2025.

  • DRW Securities reported no remaining 60 Degrees Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 6,303 60 Degrees Pharmaceuticals shares in Q4 2025, an estimated $37.3K.
  • DRW Securities first reported a position in 60 Degrees Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • DRW Securities's 60 Degrees Pharmaceuticals position peaked at $37.3K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.